Krystal Biotech (KRYS) PT Lowered to $323 at BofA Securities

May 4, 2026 10:40 AM

BofA Securities analyst Alec Stranahan lowered the price target on Krystal Biotech (NASDAQ: KRYS) to $323.00 (from $325.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found